Danaher Corporation (DHR) : Lipe Dalton reduced its stake in Danaher Corporation by 2.57% during the most recent quarter end. The investment management company now holds a total of 42,311 shares of Danaher Corporation which is valued at $3,443,692 after selling 1,117 shares in Danaher Corporation , the firm said in a disclosure report filed with the SEC on Aug 12, 2016.Danaher Corporation makes up approximately 2.55% of Lipe Dalton’s portfolio.
Other Hedge Funds, Including , Tower Bridge Advisors reduced its stake in DHR by selling 2,953 shares or 3.76% in the most recent quarter. The Hedge Fund company now holds 75,593 shares of DHR which is valued at $6,152,514. Danaher Corporation makes up approx 0.74% of Tower Bridge Advisors’s portfolio.Dixon Hubard Feinour Brown Incva boosted its stake in DHR in the latest quarter, The investment management firm added 50,945 additional shares and now holds a total of 58,993 shares of Danaher Corporation which is valued at $4,801,440. Danaher Corporation makes up approx 1.48% of Dixon Hubard Feinour Brown Incva’s portfolio.Columbia Partners L L C Investment Management reduced its stake in DHR by selling 38,226 shares or 57.9% in the most recent quarter. The Hedge Fund company now holds 27,793 shares of DHR which is valued at $2,262,072. Danaher Corporation makes up approx 0.16% of Columbia Partners L L C Investment Management’s portfolio.Highland Capital Management reduced its stake in DHR by selling 10 shares or 0.1% in the most recent quarter. The Hedge Fund company now holds 9,537 shares of DHR which is valued at $776,216. Danaher Corporation makes up approx 0.06% of Highland Capital Management’s portfolio.
Danaher Corporation opened for trading at $81.19 and hit $82.08 on the upside on Monday, eventually ending the session at $81.84, with a gain of 0.79% or 0.64 points. The heightened volatility saw the trading volume jump to 25,27,394 shares. Company has a market cap of $56,514 M.
On the company’s financial health, Danaher Corporation reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $1.22. The company had revenue of $5785.00 million for the quarter, compared to analysts expectations of $5766.84 million. The company’s revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.
Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016.
Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Companys diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Companys Industrial Technologies solutions help protect the worlds food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.